Seattle 2018

Thank You Speakers!

Seattle 2018

Washington State Convention Center

CareDx Booth #619

On Monday evening, June 4, 2018, CareDx announced its Living Donor Employee Recovery (LIDER) Policy. View Policy. View Press Release.

CareDx Lunch Symposium*

Innovation in Allograft Health Surveillance: Clinical Implementation of AlloSure Testing for Kidney Transplant Recipients

Tuesday, June 5 – 1:00 pm – Sheraton Hotel, Metropolitan Ballroom A/B

Program, View Presentation:

Moderator: Matthew Weir, M.D., Professor of Medicine, Director of the Division of Nephrology, University of Maryland

Evolving role of molecular diagnostics in Banff criteria for diagnosis of acute antibody mediated rejection (ABMR)

  • Mark Haas, M.D., Ph.D., Senior Attending Renal Pathologist; Professor, Cedars-Sinai Professorial Series, Dept. of Pathology & Laboratory Medicine – Cedars-Sinai Medical Center

Introduction to AlloSure – donor-derived cell-free DNA (dd-cfDNA) – testing and implementation into clinical practice

  • Alexander Wiseman, M.D., Professor of Medicine; Medical Director, Renal and Transplant Programs – University of Colorado

New approaches in ABMR diagnosis and assessing responses to treatment of ABMR

  • Stanley C. Jordan, M.D., Director, Division of Nephrology; Medical Director, Kidney Transplant Program; Medical Director, Human Leukocyte Antigen and Transplant Immunology Laboratory – Cedars-Sinai Comprehensive Transplant Center

Clinical experience using AlloSure for kidney transplant recipients 

  • Case Study – Kalathil K. SureshKumar, M.D., Medical Director, Kidney and Pancreas Transplant Program – Allegheny General Hospital, Allegheny Health Network
  • Case Study – Angelina Edwards, M.D., Assistant Professor of Medicine – UT Houston; Abdominal Transplant Center – Memorial Hermann Hospital
  • Case Study – Praveen Kandula, M.D., Staff Physician, Transplant Nephrology, Renal and Pancreas Transplant Division – Saint Barnabas Medical Center
  • Case Study – Vinaya Rao, M.D., Professor, Medical Director, Kidney Transplant – Medical University of South Carolina

*This symposium is not part of the ATC official educational program and the sessions and content are not endorsed by ATC

 

 

Poster presentations and oral presentations highlighting AlloSure:

Repeat Kidney Transplant Patients with Active Rejection Have Elevated Donor-Derived Cell-Free DNA. View poster.

Shikha Mehta, M.D.

Session: Poster Session A: Kidney Acute Antibody Mediated Rejection

Publication/Poster Board Number: A98

Donor-Derived Cell-Free DNA Outperforms Serum Creatinine Changes for Identifying Kidney Transplant Rejection. View poster.

Matthew R. Weir, M.D.

Session: Poster Session A: Kidney Acute Antibody Mediated Rejection

Publication/Poster Board Number: A90

Donor-Derived Cell-Free DNA Identifies Antibody-Mediated Rejection with Graft Injury in DSA-Positive Kidney Transplant Recipients. View presentation.

Stanley C. Jordan, M.D.

Session: Concurrent Session: Kidney Acute Antibody Mediated Rejection

Publication Number: 24 Presentation

Clinically Relevant Variation of Donor-Derived Cell-Free DNA During Longitudinal Surveillance of Renal Allografts. View poster.

Mohanram Narayanan, M.D.

Session: Poster Session D: Kidney: Acute Cellular Rejection

Publication/Poster Board Number: D194